Piramal Pharma Solutions expands peptide API production in India

Piramal Pharma Solutions has commissioned a new spray drying unit at its dedicated peptide manufacturing site in Turbhe, India. This expansion enhances the company's capacity to handle complex peptides and addresses the increasing demand from the pharmaceutical industry for specialized molecules.

The unit features Class 5 containment capabilities, designed for safe and efficient operations. This level of containment is critical for handling high-potency Active Pharmaceutical Ingredients (APIs), where stringent safety and quality protocols are required. The new equipment allows for end-to-end peptide manufacturing within a single facility.

This investment at the Turbhe facility responds to the pharmaceutical sector's growing need, as demand for high-grade peptides has significantly increased in recent years. Piramal Pharma Solutions aims to strengthen its position in peptide manufacturing by offering integrated services and improved production capabilities.

The company has focused on expanding its specialized drug manufacturing capacity to meet the requirements of global clients. This expansion is part of a broader strategy to enhance its offerings and increase market share in the pharmaceutical ingredients sector.